Harbour Investments »

Pliant Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $453 25 18.12
2023-09-30 $434 25 17.36
2021-09-30 $6.0k 381 15.75
2021-06-30 $10k 350 28.57
2021-03-31 $14k 348 40.23

More positions owned by Harbour Investments

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pacer Fds Tr Pacer Us Small (CALF)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Apple (AAPL)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Value Line Divid In SHS (FVD)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Fidelity Covington Trust Msci Hlth Care I (FHLC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Procter & Gamble Company (PG)

View all positions for Harbour Investments

Top funds holding Pliant Therapeutics

T. Rowe Price Associates
First Light Asset Management
Laurion Capital Management
Vanguard Group
Blue Owl Capital Holdings
Redmile Group
Trv Gp Iv
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Franklin Resources
Casdin Capital
RA Capital Management
Deutsche Bank Aktiengesellschaft
Bessemer
Candriam Luxembourg S.C.A.

View all funds holding Pliant Therapeutics